1. Home
  2. EARN vs NYXH Comparison

EARN vs NYXH Comparison

Compare EARN & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

HOLD

Current Price

$4.79

Market Cap

172.1M

Sector

Real Estate

ML Signal

HOLD

Logo Nyxoah SA

NYXH

Nyxoah SA

HOLD

Current Price

$3.02

Market Cap

152.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EARN
NYXH
Founded
2012
2009
Country
United States
Belgium
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
172.1M
152.8M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
EARN
NYXH
Price
$4.79
$3.02
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$5.38
$9.33
AVG Volume (30 Days)
392.7K
30.2K
Earning Date
06-16-2026
05-12-2026
Dividend Yield
20.51%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.69
$213.98
Revenue Next Year
$19.57
$126.25
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.27
$2.76
52 Week High
$6.08
$8.64

Technical Indicators

Market Signals
Indicator
EARN
NYXH
Relative Strength Index (RSI) 59.02 43.89
Support Level $4.54 $2.78
Resistance Level $5.36 $3.37
Average True Range (ATR) 0.09 0.14
MACD 0.02 0.01
Stochastic Oscillator 92.11 28.57

Price Performance

Historical Comparison
EARN
NYXH

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: